By Nigel Somerville, the Deputy Sheriff of AIM | Sunday 11 October 2020
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
AIM-listed Catenae Innovation (CTEA) is rapidly losing its Covid appeal. Having ended the pre-Covid period at around 0.26p per share, the company jumped on the Covid bandwagon and saw its shares roof it to peak at over 9p. But since the end of August Catenae’s lustre had dulled and now the shares are at 2.3p. It seems that what goes up must come down and as such there seems to be a long way to go. One reason could be related to its bandwagon Onsite-ID App, which we were led to believe would see some results as part of Newcastle Premier Health’s Access Planning Control. So what has happened? On 25 August we were told:
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.